Ulcolind Rani en es it fr

Ulcolind Rani Brand names, Ulcolind Rani Analogs

Ulcolind Rani Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Ulcolind Rani Chemical_Formula


Ulcolind Rani RX_link


Ulcolind Rani fda sheet

Ulcolind_Rani FDA

Ulcolind Rani msds (material safety sheet)

Ulcolind_Rani MSDS

Ulcolind Rani Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ulcolind Rani Molecular Weight

314.405 g/mol

Ulcolind Rani Melting Point

69-70 oC

Ulcolind Rani H2O Solubility

24.7 mg/mL

Ulcolind Rani State


Ulcolind Rani LogP


Ulcolind Rani Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ulcolind Rani Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ulcolind Rani Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ulcolind Rani Absorption

Approximately 50% bioavailability orally.

Ulcolind Rani side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ulcolind Rani Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ulcolind Rani Organisms Affected

Humans and other mammals